IRD vs BIIB: Which Stock is Better?
Side-by-side comparison of Opus Genetics Inc and Biogen Inc in 2026
IRD
Opus Genetics Inc
$5.71
BIIB
Biogen Inc
$180.54
Key Metrics Comparison
| Metric | IRD | BIIB | Winner |
|---|---|---|---|
| Market Cap | $396.30M | $26.50B | BIIB |
| P/E Ratio | N/A | 20.54 | BIIB |
| EPS (TTM) | $N/A | $8.79 | BIIB |
| Revenue Growth | -0.1% | -0.1% | BIIB |
| Gross Margin | -117.0% | 78.9% | BIIB |
Analyze IRD
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRD or BIIB a better investment?
Comparing IRD and BIIB: Opus Genetics Inc has a market cap of $396.30M while Biogen Inc has $26.50B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRD and BIIB?
IRD (Opus Genetics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRD or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRD or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.1% for IRD.
Which company is more profitable: IRD or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -117.0% for IRD.
Which is the larger company: IRD or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.50B compared to $396.30M for IRD.
Should I buy IRD or BIIB in 2026?
Both IRD and BIIB have investment merit. IRD trades at $5.71 while BIIB trades at $180.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRD and BIIB stock?
Key differences: Market Cap ($396.30M vs $26.50B), P/E Ratio (N/A vs 20.5x), Revenue Growth (-0.1% vs -0.1%), Gross Margin (-117.0% vs 78.9%).